Luis Ferran
Impact in
- Clinical Biochemistry top 0.2%
- Advanced Glycation End Products research
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Natural Antidiabetic Agents Studies
Papers in
-
- Advanced Glycation End Products research 3
-
- S100 Proteins and Annexins 1
- Co-authors
- Ann Marie Schmidt (4 shared papers)David M. Stern (3 shared papers)Yan Lü (3 shared papers)Wing Chow (1 shared paper)Lisa Park (1 shared paper)Kathleen G. Raman (1 shared paper)Nozomu Tanji (2 shared papers)M. Hofmann (2 shared papers)
- Journals
- Journal of Clinical Investigation (2 papers)Nature Medicine (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)Cancer Immunology Research (1 paper)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Luis Ferran
5 papers receiving 1.9k citations
Luis Ferran's Hit Papers
Peers
Comparison fields: 5 of 91
- Clinical Biochemistry 1.1k
- Endocrinology, Diabetes and Metabolism 488
- Nephrology 169
- Rheumatology 300
- Immunology 261
Countries citing papers authored by Luis Ferran
This map shows the geographic impact of Luis Ferran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Ferran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Ferran more than expected).
Fields of papers citing papers by Luis Ferran
This network shows the impact of papers produced by Luis Ferran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Ferran. The network helps show where Luis Ferran may publish in the future.
Co-authors
The 25 scholars most cited alongside Luis Ferran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts Hit paper breakdown → | 1998 | 972 |
| 2 | 2001 | 450 | |
| 3 | 1996 | 256 | |
| 4 | 2001 | 252 | |
| 5 | 2013 | 58 |
About Luis Ferran
Luis Ferran is a scholar working on Clinical Biochemistry, Molecular Biology, Nephrology, Rheumatology and Hematology, having authored 5 papers that have together received 2.0k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (3 papers), Folate and B Vitamins Research (1 paper), Natural Antidiabetic Agents Studies (1 paper), Alzheimer's disease research and treatments (1 paper), Trace Elements in Health (1 paper), Immunotherapy and Immune Responses (1 paper), Chronic Kidney Disease and Diabetes (1 paper) and S100 Proteins and Annexins (1 paper). The work is most often cited by research in Clinical Biochemistry (1.1k citations), Endocrinology, Diabetes and Metabolism (488 citations), Nephrology (169 citations), Rheumatology (300 citations) and Immunology (261 citations). Luis Ferran has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Ann Marie Schmidt, David M. Stern, Yan Lü, Wing Chow, Lisa Park, Kathleen G. Raman, Nozomu Tanji, M. Hofmann, Evanthia Lalla and Brigitte Kohl. Their work appears in journals such as Journal of Clinical Investigation, Nature Medicine, Arteriosclerosis Thrombosis and Vascular Biology and Cancer Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.